Found: 19
Select item for more details and to access through your institution.
Real Life Population Pharmacokinetics Modelling of Eight Factors VIII in Patients with Severe Haemophilia A: Is It Always Relevant to Switch to an Extended Half-Life?
- Published in:
- Pharmaceutics, 2020, v. 12, n. 4, p. 380, doi. 10.3390/pharmaceutics12040380
- By:
- Publication type:
- Article
Biological, clinical features and modelling of heterozygous variants of glycoprotein Ib platelet subunit alpha (GP1BA) and glycoprotein Ib platelet subunit beta (GP1BB) genes responsible for constitutional thrombocytopenia.
- Published in:
- British Journal of Haematology, 2022, v. 199, n. 5, p. 744, doi. 10.1111/bjh.18462
- By:
- Publication type:
- Article
Bleeding risk for patients with haemophilia under antithrombotic therapy. Results of the French multicentric study ERHEA.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 4, p. 764, doi. 10.1111/bjh.15606
- By:
- Publication type:
- Article
Simoctocog alfa (Nuwiq®) in previously untreated patients with severe haemophilia A—Final efficacy and safety results from the NuProtect study.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 4, p. 544, doi. 10.1111/ejh.14040
- By:
- Publication type:
- Article
Management of rare inherited bleeding disorders: Proposals of the French Reference Centre on Haemophilia and Rare Coagulation Disorders.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 6, p. 584, doi. 10.1111/ejh.13941
- By:
- Publication type:
- Article
rFVIII‐Fc in severe haemophilia A: The incentive switch in case of high risk of joint bleedings.
- Published in:
- European Journal of Clinical Investigation, 2022, v. 52, n. 10, p. 1, doi. 10.1111/eci.13824
- By:
- Publication type:
- Article
Recurrent V75M mutation within the Wiskott–Aldrich syndrome protein: description of a homozygous female patient.
- Published in:
- European Journal of Haematology, 2005, v. 75, n. 1, p. 54, doi. 10.1111/j.1600-0609.2005.00415.x
- By:
- Publication type:
- Article
Key Drivers of Coagulation Factor Use in Von Willebrand Disease During Hospitalization: An Overview of the French BERHLINGO Cohort.
- Published in:
- Clinical Drug Investigation, 2024, v. 44, n. 1, p. 35, doi. 10.1007/s40261-023-01323-1
- By:
- Publication type:
- Article
Thrombin generation in patients with acquired haemophilia and clinical bleeding risk.
- Published in:
- British Journal of Haematology, 2011, v. 153, n. 1, p. 136, doi. 10.1111/j.1365-2141.2010.08517.x
- By:
- Publication type:
- Article
Circulating microparticles are elevated in haemophiliacs and non-haemophilic individuals aged <18 years.
- Published in:
- British Journal of Haematology, 2005, v. 131, n. 4, p. 487, doi. 10.1111/j.1365-2141.2005.05792.x
- By:
- Publication type:
- Article
Protein A Sepharose immunoadsorption can restore the efficacy of platelet concentrates in patients with Glanzmann's thrombasthenia and anti-glycoprotein IIb–IIIa antibodies.
- Published in:
- British Journal of Haematology, 2002, v. 119, n. 4, p. 991, doi. 10.1046/j.1365-2141.2002.03936.x
- By:
- Publication type:
- Article
Detection of 95 novel mutations in coagulation factor VIII gene F8 responsible for hemophilia A: results from a single institution.
- Published in:
- Human Mutation, 2006, v. 27, n. 7, p. 676, doi. 10.1002/humu.20345
- By:
- Publication type:
- Article
Five new F10 variants in hereditary factor x deficiency detected by high‐throughput sequencing.
- Published in:
- Haemophilia, 2023, v. 29, n. 6, p. 1565, doi. 10.1111/hae.14888
- By:
- Publication type:
- Article
A focus on dominant negative variants in a series of 170 heterozygous FXI‐deficient patients.
- Published in:
- Haemophilia, 2023, v. 29, n. 4, p. 1113, doi. 10.1111/hae.14802
- By:
- Publication type:
- Article
Prostate biopsy and prostate cancer management in patients with haemophilia: The experience of French Haemophilia Treatment Centres.
- Published in:
- Haemophilia, 2022, v. 28, n. 3, p. 437, doi. 10.1111/hae.14507
- By:
- Publication type:
- Article
Bleeding complications during pregnancy and delivery in haemophilia carriers and their neonates in Western France: An observational study.
- Published in:
- Haemophilia, 2020, v. 26, n. 6, p. 1046, doi. 10.1111/hae.14117
- By:
- Publication type:
- Article
Postauthorization safety surveillance study of antihaemophilic factor (recombinant) reconstituted in 2 mL sterile water for injection in children with haemophilia A.
- Published in:
- Haemophilia, 2020, v. 26, n. 3, p. 478, doi. 10.1111/hae.13997
- By:
- Publication type:
- Article
Matching-Adjusted Indirect Comparison of Recombinant Factor IX Albumin Fusion Protein Versus Recombinant Factor IX Fc Fusion Protein for Weekly Prophylactic Treatment of Hemophilia B.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 2, p. 649, doi. 10.1007/s12325-023-02745-1
- By:
- Publication type:
- Article
ACQUIRED HEMOPHILIA IN OLDER PEOPLE: A POOR PROGNOSIS DESPITE INTENSIVE CARE.
- Published in:
- 2007
- By:
- Publication type:
- Letter